Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups.
Identifieur interne : 000330 ( Main/Exploration ); précédent : 000329; suivant : 000331Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups.
Auteurs : O. Glehen [France] ; V. Kepenekian [France] ; O. Bouché [France] ; L. Gladieff [France] ; C. Honore [France]Source :
- Journal of visceral surgery [ 1878-7886 ] ; 2020.
Descripteurs français
- KwdFr :
- MESH :
- organisation et administration : Priorités en santé.
- secondaire : Tumeurs du péritoine.
- thérapie : Tumeurs du péritoine.
- Humains, Infections à coronavirus, Pandémies, Pneumopathie virale.
English descriptors
- KwdEn :
- MESH :
- organization & administration : Health Priorities.
- secondary : Peritoneal Neoplasms.
- therapy : Peritoneal Neoplasms.
- Coronavirus Infections, Humans, Pandemics, Pneumonia, Viral.
Abstract
The Covid-19 pandemic is profoundly changing the organization of healthcare access. This is particularly so for peritoneal neoplastic diseases, for which curative treatment mobilizes substantial personnel, operating room and intensive care resources. The BIG-RENAPE and RENAPE groups have made tentative proposals for prioritizing care provision. A tightening of the usual selection criteria is needed for curative care: young patients with few or no comorbidities and limited peritoneal extension. It is desirable to prioritize disease conditions for which cytoreduction surgery with or without associated hyperthermic intraoperative peritoneal chemotherapy (HIPEC) is the gold-standard treatment, and for which systemic chemotherapy cannot be a temporary or long-term alternative: pseudomyxoma peritonei, resectable malignant peritoneal mesotheliomas, peritoneal metastases of colorectal origin if they are resectable and unresponsive to systemic chemotherapy after up to 12 courses, first-line ovarian carcinomatosis if resectable or in interval surgery after at most six courses of systemic chemotherapy. Addition of HIPEC must be discussed case by case in an expert center. The prioritization of indications must consider local conditions and the phase of the epidemic to allow optimal peri-operative care.
DOI: 10.1016/j.jviscsurg.2020.04.013
PubMed: 32387058
PubMed Central: PMC7177076
Affiliations:
- France
- Auvergne-Rhône-Alpes, Champagne-Ardenne, Grand Est, Midi-Pyrénées, Occitanie (région administrative), Rhône-Alpes
- Lyon, Reims, Toulouse, Villejuif
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups.</title><author><name sortKey="Glehen, O" sort="Glehen, O" uniqKey="Glehen O" first="O" last="Glehen">O. Glehen</name><affiliation wicri:level="3"><nlm:affiliation>Service de chirurgie digestive et endocrinienne, hôpital Lyon Sud - Hospices Civils de Lyon, 165, chemin du Grand Revoyet, 69495 Pierre-Bénite, France; EA 3738, Université Lyon 1, Lyon, France. Electronic address: olivier.glehen@chu-lyon.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de chirurgie digestive et endocrinienne, hôpital Lyon Sud - Hospices Civils de Lyon, 165, chemin du Grand Revoyet, 69495 Pierre-Bénite, France; EA 3738, Université Lyon 1, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Kepenekian, V" sort="Kepenekian, V" uniqKey="Kepenekian V" first="V" last="Kepenekian">V. Kepenekian</name><affiliation wicri:level="3"><nlm:affiliation>Service de chirurgie digestive et endocrinienne, hôpital Lyon Sud - Hospices Civils de Lyon, 165, chemin du Grand Revoyet, 69495 Pierre-Bénite, France; EA 3738, Université Lyon 1, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de chirurgie digestive et endocrinienne, hôpital Lyon Sud - Hospices Civils de Lyon, 165, chemin du Grand Revoyet, 69495 Pierre-Bénite, France; EA 3738, Université Lyon 1, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Bouche, O" sort="Bouche, O" uniqKey="Bouche O" first="O" last="Bouché">O. Bouché</name><affiliation wicri:level="3"><nlm:affiliation>Service d'hépato-gastro-entérologie et cancérologie digestive, hôpital Robert-Debré, Reims, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service d'hépato-gastro-entérologie et cancérologie digestive, hôpital Robert-Debré, Reims</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Champagne-Ardenne</region><settlement type="city">Reims</settlement></placeName></affiliation></author><author><name sortKey="Gladieff, L" sort="Gladieff, L" uniqKey="Gladieff L" first="L" last="Gladieff">L. Gladieff</name><affiliation wicri:level="3"><nlm:affiliation>Département d'oncologie médicale, institut universitaire du cancer de Toulouse, Toulouse, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département d'oncologie médicale, institut universitaire du cancer de Toulouse, Toulouse</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Midi-Pyrénées</region><settlement type="city">Toulouse</settlement></placeName></affiliation></author><author><name sortKey="Honore, C" sort="Honore, C" uniqKey="Honore C" first="C" last="Honore">C. Honore</name><affiliation wicri:level="3"><nlm:affiliation>Département de chirurgie, institut Gustave-Roussy, Villejuif, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département de chirurgie, institut Gustave-Roussy, Villejuif</wicri:regionArea><placeName><settlement type="city">Villejuif</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32387058</idno><idno type="pmid">32387058</idno><idno type="doi">10.1016/j.jviscsurg.2020.04.013</idno><idno type="pmc">PMC7177076</idno><idno type="wicri:Area/Main/Corpus">001383</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001383</idno><idno type="wicri:Area/Main/Curation">001383</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001383</idno><idno type="wicri:Area/Main/Exploration">001383</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups.</title><author><name sortKey="Glehen, O" sort="Glehen, O" uniqKey="Glehen O" first="O" last="Glehen">O. Glehen</name><affiliation wicri:level="3"><nlm:affiliation>Service de chirurgie digestive et endocrinienne, hôpital Lyon Sud - Hospices Civils de Lyon, 165, chemin du Grand Revoyet, 69495 Pierre-Bénite, France; EA 3738, Université Lyon 1, Lyon, France. Electronic address: olivier.glehen@chu-lyon.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de chirurgie digestive et endocrinienne, hôpital Lyon Sud - Hospices Civils de Lyon, 165, chemin du Grand Revoyet, 69495 Pierre-Bénite, France; EA 3738, Université Lyon 1, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Kepenekian, V" sort="Kepenekian, V" uniqKey="Kepenekian V" first="V" last="Kepenekian">V. Kepenekian</name><affiliation wicri:level="3"><nlm:affiliation>Service de chirurgie digestive et endocrinienne, hôpital Lyon Sud - Hospices Civils de Lyon, 165, chemin du Grand Revoyet, 69495 Pierre-Bénite, France; EA 3738, Université Lyon 1, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de chirurgie digestive et endocrinienne, hôpital Lyon Sud - Hospices Civils de Lyon, 165, chemin du Grand Revoyet, 69495 Pierre-Bénite, France; EA 3738, Université Lyon 1, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Bouche, O" sort="Bouche, O" uniqKey="Bouche O" first="O" last="Bouché">O. Bouché</name><affiliation wicri:level="3"><nlm:affiliation>Service d'hépato-gastro-entérologie et cancérologie digestive, hôpital Robert-Debré, Reims, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service d'hépato-gastro-entérologie et cancérologie digestive, hôpital Robert-Debré, Reims</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Champagne-Ardenne</region><settlement type="city">Reims</settlement></placeName></affiliation></author><author><name sortKey="Gladieff, L" sort="Gladieff, L" uniqKey="Gladieff L" first="L" last="Gladieff">L. Gladieff</name><affiliation wicri:level="3"><nlm:affiliation>Département d'oncologie médicale, institut universitaire du cancer de Toulouse, Toulouse, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département d'oncologie médicale, institut universitaire du cancer de Toulouse, Toulouse</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Midi-Pyrénées</region><settlement type="city">Toulouse</settlement></placeName></affiliation></author><author><name sortKey="Honore, C" sort="Honore, C" uniqKey="Honore C" first="C" last="Honore">C. Honore</name><affiliation wicri:level="3"><nlm:affiliation>Département de chirurgie, institut Gustave-Roussy, Villejuif, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département de chirurgie, institut Gustave-Roussy, Villejuif</wicri:regionArea><placeName><settlement type="city">Villejuif</settlement></placeName></affiliation></author></analytic><series><title level="j">Journal of visceral surgery</title><idno type="eISSN">1878-7886</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Coronavirus Infections (MeSH)</term><term>Health Priorities (organization & administration)</term><term>Humans (MeSH)</term><term>Pandemics (MeSH)</term><term>Peritoneal Neoplasms (secondary)</term><term>Peritoneal Neoplasms (therapy)</term><term>Pneumonia, Viral (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Humains (MeSH)</term><term>Infections à coronavirus (MeSH)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (MeSH)</term><term>Priorités en santé (organisation et administration)</term><term>Tumeurs du péritoine (secondaire)</term><term>Tumeurs du péritoine (thérapie)</term></keywords><keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Priorités en santé</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Health Priorities</term></keywords><keywords scheme="MESH" qualifier="secondaire" xml:lang="fr"><term>Tumeurs du péritoine</term></keywords><keywords scheme="MESH" qualifier="secondary" xml:lang="en"><term>Peritoneal Neoplasms</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Peritoneal Neoplasms</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Tumeurs du péritoine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Coronavirus Infections</term><term>Humans</term><term>Pandemics</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Infections à coronavirus</term><term>Pandémies</term><term>Pneumopathie virale</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The Covid-19 pandemic is profoundly changing the organization of healthcare access. This is particularly so for peritoneal neoplastic diseases, for which curative treatment mobilizes substantial personnel, operating room and intensive care resources. The BIG-RENAPE and RENAPE groups have made tentative proposals for prioritizing care provision. A tightening of the usual selection criteria is needed for curative care: young patients with few or no comorbidities and limited peritoneal extension. It is desirable to prioritize disease conditions for which cytoreduction surgery with or without associated hyperthermic intraoperative peritoneal chemotherapy (HIPEC) is the gold-standard treatment, and for which systemic chemotherapy cannot be a temporary or long-term alternative: pseudomyxoma peritonei, resectable malignant peritoneal mesotheliomas, peritoneal metastases of colorectal origin if they are resectable and unresponsive to systemic chemotherapy after up to 12 courses, first-line ovarian carcinomatosis if resectable or in interval surgery after at most six courses of systemic chemotherapy. Addition of HIPEC must be discussed case by case in an expert center. The prioritization of indications must consider local conditions and the phase of the epidemic to allow optimal peri-operative care.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32387058</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>06</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-7886</ISSN><JournalIssue CitedMedium="Internet"><Volume>157</Volume><Issue>3S1</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of visceral surgery</Title><ISOAbbreviation>J Visc Surg</ISOAbbreviation></Journal><ArticleTitle>Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups.</ArticleTitle><Pagination><MedlinePgn>S25-S31</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1878-7886(20)30118-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jviscsurg.2020.04.013</ELocationID><Abstract><AbstractText>The Covid-19 pandemic is profoundly changing the organization of healthcare access. This is particularly so for peritoneal neoplastic diseases, for which curative treatment mobilizes substantial personnel, operating room and intensive care resources. The BIG-RENAPE and RENAPE groups have made tentative proposals for prioritizing care provision. A tightening of the usual selection criteria is needed for curative care: young patients with few or no comorbidities and limited peritoneal extension. It is desirable to prioritize disease conditions for which cytoreduction surgery with or without associated hyperthermic intraoperative peritoneal chemotherapy (HIPEC) is the gold-standard treatment, and for which systemic chemotherapy cannot be a temporary or long-term alternative: pseudomyxoma peritonei, resectable malignant peritoneal mesotheliomas, peritoneal metastases of colorectal origin if they are resectable and unresponsive to systemic chemotherapy after up to 12 courses, first-line ovarian carcinomatosis if resectable or in interval surgery after at most six courses of systemic chemotherapy. Addition of HIPEC must be discussed case by case in an expert center. The prioritization of indications must consider local conditions and the phase of the epidemic to allow optimal peri-operative care.</AbstractText><CopyrightInformation>Copyright © 2020 Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Glehen</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Service de chirurgie digestive et endocrinienne, hôpital Lyon Sud - Hospices Civils de Lyon, 165, chemin du Grand Revoyet, 69495 Pierre-Bénite, France; EA 3738, Université Lyon 1, Lyon, France. Electronic address: olivier.glehen@chu-lyon.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kepenekian</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Service de chirurgie digestive et endocrinienne, hôpital Lyon Sud - Hospices Civils de Lyon, 165, chemin du Grand Revoyet, 69495 Pierre-Bénite, France; EA 3738, Université Lyon 1, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouché</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Service d'hépato-gastro-entérologie et cancérologie digestive, hôpital Robert-Debré, Reims, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gladieff</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Département d'oncologie médicale, institut universitaire du cancer de Toulouse, Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honore</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Département de chirurgie, institut Gustave-Roussy, Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>RENAPE-BIG-RENAPE</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>J Visc Surg</MedlineTA><NlmUniqueID>101532664</NlmUniqueID><ISSNLinking>1878-7886</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006292" MajorTopicYN="N">Health Priorities</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010534" MajorTopicYN="N">Peritoneal Neoplasms</DescriptorName><QualifierName UI="Q000556" MajorTopicYN="Y">secondary</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coronavirus</Keyword><Keyword MajorTopicYN="N">Covid-19</Keyword><Keyword MajorTopicYN="N">Peritoneal metastases</Keyword><Keyword MajorTopicYN="N">Primary peritoneal tumor</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Abba</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Service de chirurgie digestive et de l'urgence, CHU Grenoble Alpes, Grenoble, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Abboud</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Service de chirurgie générale et thoracique, CHU Saint-Etienne, Saint-Etienne, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Arvieux</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Service de chirurgie digestive et de l'urgence, CHU Grenoble Alpes, Grenoble, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bakrin</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Service de chirurgie digestive et endocrinienne, Hôpital Lyon Sud, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Delhorme</LastName><ForeName>J-B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Service de chirurgie générale et digestive, hôpital de Haute-Pierre, Strasbourg, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dartigues</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Département d'anatomie pathologique, institut Gustave-Roussy, Villejuif, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Durand-Fontanier</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Service de chirurgie digestive, générale et endocrinienne, hôpital Dupuytren, Limoges, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Eveno</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Service de chirurgie générale et digestive, hôpital Claude-Huriez, Lille, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fontaine</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Service d'Anatomie Pathologique, hôpital Lyon Sud, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gelli</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Département de chirurgie, Institut Gustave Roussy, Villejuif, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Goere</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Service de chirurgie viscérale, cancérologique et endocrinienne, Hôpital Saint-Louis, Paris, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Guyon</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Département de chirurgie oncologique, institut Bergonié, Bordeaux, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lefevre</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Service de chirurgie digestive, hôpital Saint-Antoine, Paris, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lo Dico</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Service de chirurgie viscérale, cancérologique et endocrinienne, Hôpital Saint-Louis, Paris, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Marchal</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Département de chirurgie, institut de cancérologie de Lorraine-Alexis-Vautrin, Vandœuvre-lès-Nancy, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nadeau</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Service de gynécologie, hôpital de la Miletrie, Poitiers, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Paquette</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Service de chirurgie digestive, hôpital Jean-Minjoz, Besançon, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pezet</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Service de chirurgie digestive et hépatobiliaire, hôpital Estaing, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pocard</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Service de chirurgie viscérale, cancérologique et endocrinienne, hôpital Lariboisière, Paris, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rousset</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Service d'imagerie, hôpital Lyon Sud, hospices civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sgarbura</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Département de chirurgie, institut du cancer de Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Taibi</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Service de chirurgie digestive, générale et endocrinienne, hôpital Dupuytren, Limoges, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tuech</LastName><ForeName>J-J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Service de chirurgie digestive, hôpital Charles-Nicolle, Rouen, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>You</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Service d'oncologie médicale, hôpital Lyon Sud, hospices civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Villeneuve</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Service de recherche clinique et épidémiologique, pôle de santé publique, hospices civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32387058</ArticleId><ArticleId IdType="pii">S1878-7886(20)30118-1</ArticleId><ArticleId IdType="doi">10.1016/j.jviscsurg.2020.04.013</ArticleId><ArticleId IdType="pmc">PMC7177076</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Auvergne-Rhône-Alpes</li><li>Champagne-Ardenne</li><li>Grand Est</li><li>Midi-Pyrénées</li><li>Occitanie (région administrative)</li><li>Rhône-Alpes</li></region><settlement><li>Lyon</li><li>Reims</li><li>Toulouse</li><li>Villejuif</li></settlement></list><tree><country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Glehen, O" sort="Glehen, O" uniqKey="Glehen O" first="O" last="Glehen">O. Glehen</name></region><name sortKey="Bouche, O" sort="Bouche, O" uniqKey="Bouche O" first="O" last="Bouché">O. Bouché</name><name sortKey="Gladieff, L" sort="Gladieff, L" uniqKey="Gladieff L" first="L" last="Gladieff">L. Gladieff</name><name sortKey="Honore, C" sort="Honore, C" uniqKey="Honore C" first="C" last="Honore">C. Honore</name><name sortKey="Kepenekian, V" sort="Kepenekian, V" uniqKey="Kepenekian V" first="V" last="Kepenekian">V. Kepenekian</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000330 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000330 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32387058
|texte= Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32387058" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |